I denne undersøgelse inkluderedes 147 patienter, der randomiseredes til enten 400 mg eller 600 mg oralt en gang daglig, i op til 36 måneder.
In this study 147 patients were enrolled and randomised to receive either 400 mg or 600 mg orally once daily for up to 36 months.